Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FMJ1U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,249
Award facts
- Contract value 100% obligated
- $3,248.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 16, 2025, with a completion date of January 8, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. Benlysta (belimumab) is a monoclonal antibody used primarily for the treatment of systemic lupus erythematosus and other autoimmune conditions, representing specialized pharmaceutical support for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical supplier to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities through this comprehensive global pharmaceutical support vehicle. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FMJ1U?
SPE2DR26FMJ1U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FMJ1U worth?
The government has obligated $3,249 on SPE2DR26FMJ1U.
Is contract SPE2DR26FMJ1U an order under another contract?
Yes. SPE2DR26FMJ1U is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMJ1U competed?
The extent of competition for SPE2DR26FMJ1U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award